Food and Drug Administration-approved endovascular repair devices for abdominal aortic aneurysms: a review

Jack Wei Chieh Tan; Khung Keong Yeo; John R Laird

doi:10.1016/j.jvir.2007.12.452

Food and Drug Administration-approved endovascular repair devices for abdominal aortic aneurysms: a review

J Vasc Interv Radiol. 2008 Jun;19(6 Suppl):S9-S17. doi: 10.1016/j.jvir.2007.12.452.

Authors

Jack Wei Chieh Tan¹, Khung Keong Yeo, John R Laird

Affiliation

¹ Division of Cardiovascular Medicine, University of California Davis Medical Center, 4860 Y Street, Sacramento, CA 95817, USA.

PMID: 18502391
DOI: 10.1016/j.jvir.2007.12.452

Abstract

Endovascular treatment of infrarenal abdominal aortic aneurysm (AAA) offers a less invasive alternative to conventional open repair. Currently, only four devices are Food and Drug Administration (FDA)-approved for use in endovascular aneurysm repair (EVAR) of AAA in the United States. All four devices are associated with a high technical success rate and less morbidity than open surgical repair. Each device has its inherent design advantages and disadvantages that must be matched with patient and AAA characteristics. This review will discuss and compare the technology and procedural outcomes data of the current FDA-approved EVAR devices.

Publication types

Comparative Study
Review

MeSH terms

Aortic Aneurysm, Abdominal / therapy*
Blood Vessel Prosthesis Implantation / instrumentation*
Blood Vessel Prosthesis*
Clinical Trials as Topic
Device Approval*
Humans
Outcome Assessment, Health Care
Patient Selection
Prosthesis Design
United States
United States Food and Drug Administration